Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

CytRx PE Ratio 2006-2018 | CYTR

Current and historical p/e ratio for CytRx (CYTR) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CytRx PE ratio as of January 18, 2019 is 0.00.
CytRx PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-01-18 0.61 0.00
2018-09-30 1.05 $-0.51 0.00
2018-06-30 1.13 $-0.60 0.00
2018-03-31 1.59 $-1.10 0.00
2017-12-31 1.69 $-1.55 0.00
2017-09-30 2.46 $-1.75 0.00
2017-06-30 3.76 $-2.34 0.00
2017-03-31 2.67 $-3.36 0.00
2016-12-31 2.23 $-3.90 0.00
2016-09-30 3.53 $-5.64 0.00
2016-06-30 13.38 $-5.52 0.00
2016-03-31 16.08 $-5.16 0.00
2015-12-31 15.90 $-5.88 0.00
2015-09-30 14.22 $-5.22 0.00
2015-06-30 22.32 $-5.16 0.00
2015-03-31 20.22 $-5.58 0.00
2014-12-31 16.44 $-3.24 0.00
2014-09-30 15.24 $-6.42 0.00
2014-06-30 25.08 $-7.80 0.00
2014-03-31 20.94 $-6.78 0.00
2013-12-31 37.62 $-8.64 0.00
2013-09-30 19.38 $-2.52 0.00
2013-06-30 12.00 $-0.12 0.00
2013-03-31 16.32 $-3.24 0.00
2012-12-31 11.22 $-4.80 0.00
2012-09-30 21.78 $-7.56 0.00
2012-06-30 27.48 $-7.98 0.00
2012-03-31 16.81 $-5.46 0.00
2011-12-31 11.76 $-5.04 0.00
2011-09-30 14.15 $-1.68 0.00
2011-06-30 30.24 $-3.36 0.00
2011-03-31 36.96 $-1.68 0.00
2010-12-31 42.42 $0.42 101.05
2010-09-30 31.50 $-2.94 0.00
2010-06-30 32.34 $0.42 77.04
2010-03-31 46.62 $-0.84 0.00
2009-12-31 47.04 $-2.10 0.00
2009-09-30 47.04 $-2.52 0.00
2009-06-30 45.36 $-10.08 0.00
2009-03-31 14.70 $-11.75 0.00
2008-12-31 12.60 $-13.01 0.00
2008-09-30 21.42 $-14.27 0.00
2008-06-30 27.30 $-10.49 0.00
2008-03-31 48.30 $-10.91 0.00
2007-12-31 64.61 $-10.49 0.00
2007-09-30 78.26 $-10.07 0.00
2007-06-30 70.99 $-9.66 0.00
2007-03-31 106.66 $-10.07 0.00
2006-12-31 43.44 $-10.49 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.020B $0.000B
CYTRX CORP. is engaged in the development and commercialization of pharmaceutical related products and services including human therapeutics focused on high-value critical- care therapies.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $129.916B 14.69
Gilead Sciences (GILD) United States $89.493B 10.78
Biogen (BIIB) United States $67.984B 13.77
Celgene (CELG) United States $60.324B 11.71
Vertex Pharmaceuticals (VRTX) United States $49.757B 86.92
Illumina (ILMN) United States $45.974B 53.55
Regeneron Pharmaceuticals (REGN) United States $45.322B 22.96
Alexion Pharmaceuticals (ALXN) United States $26.114B 17.87
BioMarin Pharmaceutical (BMRN) United States $17.395B 0.00
Incyte (INCY) United States $16.688B 461.29
Seattle Genetics (SGEN) United States $11.788B 0.00
Exact Sciences (EXAS) United States $9.685B 0.00
BeiGene (BGNE) Cayman Islands $8.513B 0.00
QIAGEN (QGEN) Netherlands $8.429B 26.96
Alnylam Pharmaceuticals (ALNY) United States $8.410B 0.00
Sarepta Therapeutics (SRPT) United States $8.206B 0.00
Bluebird Bio (BLUE) United States $7.108B 0.00
Exelixis (EXEL) United States $6.772B 19.19
Bio-Techne Corp (TECH) United States $6.162B 41.63
Amarin (AMRN) Ireland $5.564B 0.00
Moderna (MRNA) United States $5.490B 0.00
Galapagos (GLPG) Belgium $5.367B 0.00
Alkermes (ALKS) Ireland $5.305B 3414.00
Array BioPharma (ARRY) United States $3.735B 0.00
Horizon Pharma Public (HZNP) Ireland $3.661B 15.06
MorphoSys AG Unsponsored ADR (MOR) Germany $3.622B 0.00
Guardant Health (GH) United States $3.537B 0.00
Allogene Therapeutics (ALLO) United States $3.472B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.364B 0.00
ARGENX SE-ADR (ARGX) Netherlands $3.283B 0.00
Emergent Biosolutions (EBS) United States $3.176B 26.76
Ascendis Pharma (ASND) Denmark $3.106B 0.00
Blueprint Medicines (BPMC) United States $3.073B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.698B 0.00
China Biologic Products (CBPO) China $2.690B 19.15
Akcea Therapeutics (AKCA) United States $2.683B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.635B 0.00
Genomic Health (GHDX) United States $2.626B 88.66
Repligen (RGEN) United States $2.558B 79.90
Global Blood Therapeutics (GBT) United States $2.553B 0.00
Immunomedics (IMMU) United States $2.535B 0.00
Ligand Pharmaceuticals (LGND) United States $2.506B 19.17
Halozyme Therapeutics (HALO) United States $2.375B 53.00
Amicus Therapeutics (FOLD) United States $2.330B 0.00
Reata Pharmaceuticals (RETA) United States $2.293B 0.00
Myriad Genetics (MYGN) United States $2.218B 21.98
Arena Pharmaceuticals (ARNA) United States $2.133B 0.00
Mirati Therapeutics (MRTX) United States $2.111B 0.00
Denali Therapeutics (DNLI) United States $2.046B 0.00
Innoviva (INVA) United States $1.987B 11.24
AnaptysBio (ANAB) United States $1.954B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.927B 0.00
Acceleron Pharma (XLRN) United States $1.893B 0.00
Insmed (INSM) United States $1.849B 0.00
MyoKardia (MYOK) United States $1.833B 0.00
Allakos (ALLK) United States $1.788B 0.00
Spark Therapeutics (ONCE) United States $1.702B 0.00
Atara Biotherapeutics (ATRA) United States $1.700B 0.00
REGENXBIO (RGNX) United States $1.689B 22.65
Vanda Pharmaceuticals (VNDA) United States $1.629B 129.38
Zai Lab Unsponsored ADR (ZLAB) China $1.511B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.486B 0.00
NeoGenomics (NEO) United States $1.478B 121.69
Medicines (MDCO) United States $1.477B 0.00
Cambrex (CBM) United States $1.461B 10.91
Aimmune Therapeutics (AIMT) United States $1.345B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.320B 0.00
Clovis Oncology (CLVS) United States $1.265B 0.00
WAVE Life Sciences (WVE) Singapore $1.255B 0.00
Myovant Sciences (MYOV) United Kingdom $1.253B 0.00
Editas Medicine (EDIT) United States $1.250B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.204B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.197B 0.00
Sangamo Therapeutics (SGMO) United States $1.186B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.186B 0.00
UniQure (QURE) Netherlands $1.169B 0.00
Lion Biotechnologies (IOVA) United States $1.160B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.120B 0.00
Rubius Therapeutics (RUBY) United States $1.104B 0.00
Audentes Therapeutics (BOLD) United States $1.048B 0.00
Fate Therapeutics (FATE) United States $1.036B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.033B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.007B 0.00
Puma Biotechnology (PBYI) United States $0.962B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.916B 0.00
Retrophin (RTRX) United States $0.916B 0.00
Solid Biosciences (SLDB) United States $0.911B 0.00
Apellis Pharmaceuticals (APLS) United States $0.837B 0.00
InflaRx (IFRX) Germany $0.827B 0.00
Athenex (ATNX) United States $0.806B 0.00
Coherus BioSciences (CHRS) United States $0.797B 0.00
Novavax (NVAX) United States $0.785B 0.00
Vericel (VCEL) United States $0.780B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.779B 0.00
Acorda Therapeutics (ACOR) United States $0.773B 9.80
Principia Biopharma (PRNB) United States $0.765B 0.00
Epizyme (EPZM) United States $0.757B 0.00
Dynavax Technologies (DVAX) United States $0.755B 0.00
CytomX Therapeutics (CTMX) United States $0.754B 0.00
G1 THERAPEUTICS (GTHX) United States $0.749B 0.00
AC Immune SA (ACIU) Switzerland $0.747B 0.00
Heska (HSKA) United States $0.735B 60.17
UROGEN PHARMA (URGN) Israel $0.703B 0.00
Cellectis (CLLS) France $0.696B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.692B 0.00
Intra-Cellular Therapies (ITCI) United States $0.687B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.676B 0.00
Intellia Therapeutics (NTLA) United States $0.660B 0.00
Revance Therapeutics (RVNC) United States $0.659B 0.00
ANI Pharmaceuticals (ANIP) United States $0.648B 12.40
RA PHARMCTL INC (RARX) United States $0.648B 0.00
Twist Bioscience (TWST) United States $0.633B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.631B 0.00
Viking Therapeutics (VKTX) United States $0.627B 0.00
Cara Therapeutics (CARA) United States $0.603B 0.00
Kura Oncology (KURA) United States $0.603B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.597B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.589B 0.00
Arvinas (ARVN) United States $0.539B 0.00
UNITY Biotechnology (UBX) $0.527B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.510B 0.00
Zymeworks (ZYME) Canada $0.508B 0.00
Anika Therapeutics (ANIK) United States $0.502B 20.77
ObsEva SA (OBSV) Switzerland $0.501B 0.00
Osiris Therapeutics (OSIR) United States $0.501B 0.00
Inovio Pharmaceuticals (INO) United States $0.485B 0.00
Prothena (PRTA) Ireland $0.477B 0.00
Eidos Therapeutics (EIDX) United States $0.465B 0.00
Zealand Pharma (ZEAL) Denmark $0.460B 5.06
Adaptimmune Therapeutics (ADAP) United Kingdom $0.459B 0.00
PDL BioPharma (PDLI) United States $0.455B 7.43
Gritstone Oncology (GRTS) United States $0.453B 0.00
Arcus Biosciences (RCUS) United States $0.447B 0.00
Mesoblast (MESO) Australia $0.444B 0.00
Agenus (AGEN) United States $0.440B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.429B 0.00
BeyondSpring (BYSI) United States $0.423B 0.00
DBV Technologies (DBVT) France $0.421B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.414B 0.00
MediciNova (MNOV) United States $0.411B 0.00
Senesco Technologies (ELOX) United States $0.406B 0.00
Synthorx (THOR) United States $0.405B 0.00
Scholar Rock Holding (SRRK) United States $0.397B 0.00
Five Prime Therapeutics (FPRX) United States $0.397B 0.00
Kezar Life Sciences (KZR) United States $0.393B 0.00
Cytokineticsorporated (CYTK) United States $0.375B 0.00
Sinovac Biotech (SVA) China $0.373B 0.00
Abeona Therapeutics (ABEO) United States $0.348B 0.00
Cellular Biomedicine (CBMG) United States $0.348B 0.00
Stemline Therapeutics (STML) United States $0.340B 0.00
Krystal Biotech (KRYS) United States $0.336B 0.00
Kindred Biosciences (KIN) United States $0.334B 0.00
Replimune (REPL) United States $0.330B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.323B 0.00
AVROBIO (AVRO) United States $0.320B 0.00
Evelo Biosciences (EVLO) United States $0.320B 0.00
Kodiak Sciences (KOD) United States $0.313B 0.00
BioDelivery Sciences (BDSI) United States $0.305B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.304B 0.00
Enochian Biosciences (ENOB) United States $0.297B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.294B 0.00
Merus (MRUS) Netherlands $0.293B 0.00
Albireo Pharma (ALBO) United States $0.289B 0.00
Sorrento Therapeutics (SRNE) United States $0.281B 0.00
MeiraGTx Holdings (MGTX) United States $0.275B 0.00
Kadmon Holdings (KDMN) United States $0.273B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.264B 0.00
Gamida Cell (GMDA) Israel $0.262B 0.00
Urovant Sciences (UROV) United States $0.261B 0.00
Verastem (VSTM) United States $0.255B 0.00
Intec Pharma (NTEC) Israel $0.247B 0.00
Axsome Therapeutics (AXSM) United States $0.243B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.243B 0.00
ResTORbio (TORC) United States $0.242B 0.00
Seres Therapeutics (MCRB) United States $0.233B 0.00
Magenta Therapeutics (MGTA) United States $0.232B 0.00
Celcuity (CELC) United States $0.231B 0.00
Sutro Biopharma (STRO) United States $0.228B 0.00
Syros Pharmaceuticals (SYRS) United States $0.227B 0.00
Strongbridge Biopharma (SBBP) United States $0.226B 0.00
MannKind (MNKD) United States $0.225B 0.00
Celyad SA (CYAD) Belgium $0.223B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.222B 0.00
XBiotech (XBIT) United States $0.219B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.216B 0.00
Kamada (KMDA) Israel $0.215B 19.74
Aduro Biotech (ADRO) United States $0.214B 0.00
PSivida (EYPT) United States $0.214B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.214B 0.00
Liquidia Technologies (LQDA) United States $0.210B 0.00
Equillium (EQ) United States $0.209B 0.00
Cerecor (CERC) United States $0.208B 0.00
Arbutus Biopharma (ABUS) Canada $0.205B 0.00
Adverum Biotechnologies (ADVM) United States $0.204B 0.00
Geron (GERN) United States $0.203B 0.00
Athersys (ATHX) United States $0.203B 0.00
Kala Pharmaceuticals (KALA) United States $0.199B 0.00
Protagonist Therapeutics (PTGX) United States $0.197B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.193B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.186B 0.00
Allena Pharmaceuticals (ALNA) United States $0.185B 0.00
Synlogic (SYBX) United States $0.184B 0.00
ChromaDex (CDXC) United States $0.184B 0.00
CorMedix Inc (CRMD) United States $0.180B 0.00
LogicBio Therapeutics (LOGC) United States $0.180B 0.00
TOCAGEN INC (TOCA) United States $0.177B 0.00
Aptinyx (APTX) United States $0.176B 0.00
Enzo Biochem (ENZ) United States $0.173B 0.00
VBI Vaccines (VBIV) United States $0.172B 0.00
Constellation Pharmaceuticals (CNST) United States $0.163B 0.00
Compugen (CGEN) Israel $0.163B 0.00
Cohbar (CWBR) United States $0.159B 0.00
ADMA Biologics Inc (ADMA) United States $0.156B 0.00
Motif Bio Plc (MTFB) United States $0.150B 0.00
OvaScience (MLND) United States $0.145B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.144B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.144B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.143B 0.00
Palatin Technologies (PTN) United States $0.142B 17.52
Spero Therapeutics (SPRO) United States $0.139B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.134B 0.00
Pluristem Therapeutics (PSTI) Israel $0.130B 0.00
Menlo Therapeutics (MNLO) United States $0.129B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.129B 0.00
BioTime (BTX) United States $0.127B 0.00
Unum Therapeutics (UMRX) United States $0.124B 0.00
Pfenex (PFNX) United States $0.124B 0.00
Axovant Sciences (AXON) United Kingdom $0.124B 0.00
Checkpoint Therapeutics (CKPT) United States $0.123B 0.00
Cue Biopharma (CUE) United States $0.121B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.121B 0.00
Organovo Holdings (ONVO) United States $0.119B 0.00
Cocrystal Pharma (COCP) United States $0.116B 128.67
Proteostasis Therapeutics (PTI) United States $0.114B 0.00
XOMA (XOMA) United States $0.114B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.112B 0.00
VTv Therapeutics (VTVT) United States $0.109B 0.00
ETON PHARMACEUT (ETON) United States $0.107B 0.00
NantKwest (NK) United States $0.107B 0.00
Neothetics (EVFM) United States $0.103B 0.00
Catalyst Biosciences (CBIO) United States $0.095B 0.00
Signal Genetics (MGEN) United States $0.093B 0.00
PHASEBIO PHARMA (PHAS) United States $0.093B 0.00
BioXcel Therapeutics (BTAI) United States $0.092B 0.00
Chiasma (CHMA) United States $0.092B 0.00
Mustang Bio (MBIO) United States $0.090B 0.00
TIZIANA LIFE SC (TLSA) United Kingdom $0.089B 0.00
OVID THERAPEUTC (OVID) United States $0.088B 0.00
Mersana Therapeutics (MRSN) United States $0.086B 0.00
Anavex Life Sciences (AVXL) United States $0.085B 0.00
Provention Bio (PRVB) United States $0.084B 0.00
Aptose Biosciences (APTO) Canada $0.083B 0.00
VolitionRX (VNRX) Singapore $0.083B 0.00
ITUS (ANIX) United States $0.082B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.082B 0.00
Cidara Therapeutics (CDTX) United States $0.082B 0.00
Orgenesis (ORGS) United States $0.080B 0.00
Idera Pharmaceuticals (IDRA) United States $0.080B 0.00
Cel-Sci (CVM) United States $0.077B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.073B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.072B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.067B 0.00
ScPharmaceuticals (SCPH) United States $0.066B 0.00
Fortress Biotech (FBIO) United States $0.065B 0.00
Protalix BioTherapeutics (PLX) Israel $0.064B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.063B 0.00
Monster Digital (INNT) United States $0.060B 0.00
Alimera Sciences (ALIM) United States $0.060B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
Celldex Therapeutics (CLDX) United States $0.059B 0.00
AEterna Zentaris (AEZS) United States $0.058B 11.06
Ophthotech (OPHT) United States $0.057B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Vaccinex (VCNX) United States $0.057B 0.00
Oncobiologics (OTLK) United States $0.056B 0.00
Bellerophon Therapeutics (BLPH) United States $0.056B 0.00
Evogene (EVGN) Israel $0.055B 0.00
Eleven Biotherapeutics (SESN) United States $0.055B 0.00
Alcobra (ARCT) United States $0.054B 0.00
Applied Genetic Technologies (AGTC) United States $0.053B 0.00
VistaGen Therapeutics (VTGN) United States $0.052B 0.00
Proteon Therapeutics (PRTO) United States $0.051B 0.00
Caladrius Biosciences (CLBS) United States $0.049B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.047B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.047B 0.00
OncoSec Medical (ONCS) United States $0.046B 0.00
Arsanis (ASNS) United States $0.046B 0.00
Selecta Biosciences (SELB) United States $0.046B 0.00
Trevena (TRVN) United States $0.045B 0.00
Bionano Genomics (BNGO) United States $0.045B 0.00
VIVUS (VVUS) United States $0.045B 0.00
Leap Therapeutics (LPTX) United States $0.044B 0.00
Adial Pharmaceuticals (ADIL) United States $0.044B 0.00
DiaMedica Therapeutics (DMAC) United States $0.043B 0.00
Celsion (CLSN) United States $0.043B 0.00
Entera Bio (ENTX) Israel $0.042B 0.00
Versartis (ARAV) United States $0.042B 3.65
AZURRX BIOPHARM (AZRX) United States $0.041B 0.00
Vascular Biogenics (VBLT) Israel $0.041B 0.00
Asterias Biotherapeutics (AST) United States $0.041B 0.00
Moleculin Biotech (MBRX) United States $0.039B 0.00
Curis (CRIS) United States $0.038B 0.00
Sophiris Bio (SPHS) United States $0.038B 0.00
Clearside Biomedical (CLSD) United States $0.037B 0.00
Aptevo Therapeutics (APVO) United States $0.037B 0.00
AquaBounty Technologies (AQB) United States $0.036B 0.00
Oncolytics Biotech (ONCY) Canada $0.034B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.034B 0.00
Galena Biopharma (SLS) United States $0.032B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.031B 4.94
Oragenics (OGEN) United States $0.029B 0.00
TRACON Pharmaceuticals (TCON) United States $0.029B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.028B 0.00
Eyenovia (EYEN) United States $0.028B 0.00
Zosano Pharma (ZSAN) United States $0.027B 0.00
IMMURON LTD (IMRN) Australia $0.026B 0.00
BioPharmX (BPMX) United States $0.025B 0.00
Advaxis (ADXS) United States $0.024B 0.00
GTx (GTXI) United States $0.023B 0.00
GENPREX INC (GNPX) United States $0.023B 0.00
Vical (VICL) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Novelion Therapeutics (NVLN) Canada $0.018B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
Aileron Therapeutics (ALRN) United States $0.018B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.018B 0.00
ATyr Pharma (LIFE) United States $0.017B 0.00
Soligenix (SNGX) United States $0.017B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
IBio (IBIO) United States $0.016B 0.00
Benitec Biopharma (BNTC) Australia $0.016B 0.00
Cellect Biotechnology (APOP) Israel $0.016B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Novogen (KZIA) Australia $0.014B 0.00
Gemphire Therapeutics (GEMP) United States $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.014B 6.84
TrovaGene (TROV) United States $0.013B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
Edge Therapeutics (EDGE) United States $0.013B 0.00
Pulmatrix (PULM) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
Dare Bioscience (DARE) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Histogenics (HSGX) United States $0.010B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Aytu Bioscience (AYTU) United States $0.009B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
RestorGenex (DFFN) United States $0.008B 0.00
Neuralstem (CUR) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Flex Pharma (FLKS) United States $0.006B 0.00
ARCA Biopharma (ABIO) United States $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00